Cancer: Sanofi partners with Seagen to develop antibody-drug conjugates
(Reuters) – Pharmaceutical group Sanofi announced Wednesday that it is collaborating with the American laboratory Seagen to develop antibody-drug conjugates (ADCs) against up to three… Read More »Cancer: Sanofi partners with Seagen to develop antibody-drug conjugates